Global Sickle Cell Disease Drug Market Research Report 2018

June 2018 | 103 pages | ID: GAF84E98418EN
QYResearch

Abstracts

This report studies the global Sickle Cell Disease Drug market status and forecast, categorizes the global Sickle Cell Disease Drug market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
The global Sickle Cell Disease Drug market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major manufacturers covered in this report

• Acceleron Pharma Inc
• Addmedica SAS
• Angiocrine Bioscience Inc
• Annexin Pharmaceuticals AB
• ArQule Inc
• Bio Products Laboratory Ltd
• Bioverativ Inc
• bluebird bio Inc
• Bristol-Myers Squibb Co
• Calimmune Inc
• CRISPR Therapeutics
• CSL Ltd
• Daiichi Sankyo Co Ltd
• Editas Medicine Inc
• Errant Gene Therapeutics LLC
• Gamida Cell Ltd
• Genethon SA
• Gilead Sciences Inc
• Global Blood Therapeutics Inc

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• ARQ-092
• BIVV-003
• CAL-H
• CTX-001
• DRX-194
• Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Hospital
• Clinic
• Others

The study objectives of this report are:

• To analyze and study the global Sickle Cell Disease Drug sales, value, status (2013-2017) and forecast (2018-2025).
• Focuses on the key Sickle Cell Disease Drug manufacturers, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Sickle Cell Disease Drug are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Sickle Cell Disease Drug Manufacturers
Sickle Cell Disease Drug Distributors/Traders/Wholesalers
Sickle Cell Disease Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Sickle Cell Disease Drug market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Sickle Cell Disease Drug Market Research Report 2018

1 SICKLE CELL DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Sickle Cell Disease Drug
1.2 Sickle Cell Disease Drug Segment by Type (Product Category)
  1.2.1 Global Sickle Cell Disease Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Sickle Cell Disease Drug Production Market Share by Type (Product Category) in 2017
  1.2.3 ARQ-092
  1.2.4 BIVV-003
  1.2.5 CAL-H
  1.2.6 CTX-001
  1.2.7 DRX-194
  1.2.8 Others
1.3 Global Sickle Cell Disease Drug Segment by Application
  1.3.1 Sickle Cell Disease Drug Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Global Sickle Cell Disease Drug Market by Region (2013-2025)
  1.4.1 Global Sickle Cell Disease Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Sickle Cell Disease Drug (2013-2025)
  1.5.1 Global Sickle Cell Disease Drug Revenue Status and Outlook (2013-2025)
  1.5.2 Global Sickle Cell Disease Drug Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL SICKLE CELL DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Sickle Cell Disease Drug Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Sickle Cell Disease Drug Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Sickle Cell Disease Drug Production and Share by Manufacturers (2013-2018)
2.2 Global Sickle Cell Disease Drug Revenue and Share by Manufacturers (2013-2018)
2.3 Global Sickle Cell Disease Drug Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Sickle Cell Disease Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Sickle Cell Disease Drug Market Competitive Situation and Trends
  2.5.1 Sickle Cell Disease Drug Market Concentration Rate
  2.5.2 Sickle Cell Disease Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL SICKLE CELL DISEASE DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Sickle Cell Disease Drug Capacity and Market Share by Region (2013-2018)
3.2 Global Sickle Cell Disease Drug Production and Market Share by Region (2013-2018)
3.3 Global Sickle Cell Disease Drug Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL SICKLE CELL DISEASE DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Sickle Cell Disease Drug Consumption by Region (2013-2018)
4.2 North America Sickle Cell Disease Drug Production, Consumption, Export, Import (2013-2018)
4.3 Europe Sickle Cell Disease Drug Production, Consumption, Export, Import (2013-2018)
4.4 China Sickle Cell Disease Drug Production, Consumption, Export, Import (2013-2018)
4.5 Japan Sickle Cell Disease Drug Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Sickle Cell Disease Drug Production, Consumption, Export, Import (2013-2018)
4.7 India Sickle Cell Disease Drug Production, Consumption, Export, Import (2013-2018)

5 GLOBAL SICKLE CELL DISEASE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Sickle Cell Disease Drug Production and Market Share by Type (2013-2018)
5.2 Global Sickle Cell Disease Drug Revenue and Market Share by Type (2013-2018)
5.3 Global Sickle Cell Disease Drug Price by Type (2013-2018)
5.4 Global Sickle Cell Disease Drug Production Growth by Type (2013-2018)

6 GLOBAL SICKLE CELL DISEASE DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Sickle Cell Disease Drug Consumption and Market Share by Application (2013-2018)
6.2 Global Sickle Cell Disease Drug Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL SICKLE CELL DISEASE DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Acceleron Pharma Inc
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Addmedica SAS
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Addmedica SAS Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Angiocrine Bioscience Inc
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Annexin Pharmaceuticals AB
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Main Business/Business Overview
7.5 ArQule Inc
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 ArQule Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
  7.5.4 Main Business/Business Overview
7.6 Bio Products Laboratory Ltd
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Bioverativ Inc
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Bioverativ Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Main Business/Business Overview
7.8 bluebird bio Inc
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 bluebird bio Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Bristol-Myers Squibb Co
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Calimmune Inc
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Sickle Cell Disease Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Calimmune Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
  7.10.4 Main Business/Business Overview
7.11 CRISPR Therapeutics
7.12 CSL Ltd
7.13 Daiichi Sankyo Co Ltd
7.14 Editas Medicine Inc
7.15 Errant Gene Therapeutics LLC
7.16 Gamida Cell Ltd
7.17 Genethon SA
7.18 Gilead Sciences Inc
7.19 Global Blood Therapeutics Inc

8 SICKLE CELL DISEASE DRUG MANUFACTURING COST ANALYSIS

8.1 Sickle Cell Disease Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Sickle Cell Disease Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Sickle Cell Disease Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Sickle Cell Disease Drug Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL SICKLE CELL DISEASE DRUG MARKET FORECAST (2018-2025)

12.1 Global Sickle Cell Disease Drug Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Sickle Cell Disease Drug Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Sickle Cell Disease Drug Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Sickle Cell Disease Drug Price and Trend Forecast (2018-2025)
12.2 Global Sickle Cell Disease Drug Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Sickle Cell Disease Drug Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Sickle Cell Disease Drug Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Sickle Cell Disease Drug
Figure Global Sickle Cell Disease Drug Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Sickle Cell Disease Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of ARQ-092
Table Major Manufacturers of ARQ-092
Figure Product Picture of BIVV-003
Table Major Manufacturers of BIVV-003
Figure Product Picture of CAL-H
Table Major Manufacturers of CAL-H
Figure Product Picture of CTX-001
Table Major Manufacturers of CTX-001
Figure Product Picture of DRX-194
Table Major Manufacturers of DRX-194
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Sickle Cell Disease Drug Consumption (K Pcs) by Applications (2013-2025)
Figure Global Sickle Cell Disease Drug Consumption Market Share by Applications in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Sickle Cell Disease Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)
Figure North America Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Sickle Cell Disease Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Sickle Cell Disease Drug Capacity, Production (K Pcs) Status and Outlook (2013-2025)
Figure Global Sickle Cell Disease Drug Major Players Product Capacity (K Pcs) (2013-2018)
Table Global Sickle Cell Disease Drug Capacity (K Pcs) of Key Manufacturers (2013-2018)
Table Global Sickle Cell Disease Drug Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Sickle Cell Disease Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Sickle Cell Disease Drug Capacity (K Pcs) of Key Manufacturers in 2018
Figure Global Sickle Cell Disease Drug Major Players Product Production (K Pcs) (2013-2018)
Table Global Sickle Cell Disease Drug Production (K Pcs) of Key Manufacturers (2013-2018)
Table Global Sickle Cell Disease Drug Production Share by Manufacturers (2013-2018)
Figure 2017 Sickle Cell Disease Drug Production Share by Manufacturers
Figure 2017 Sickle Cell Disease Drug Production Share by Manufacturers
Figure Global Sickle Cell Disease Drug Major Players Product Revenue (Million USD) (2013-2018)
Table Global Sickle Cell Disease Drug Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Sickle Cell Disease Drug Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Sickle Cell Disease Drug Revenue Share by Manufacturers
Table 2018 Global Sickle Cell Disease Drug Revenue Share by Manufacturers
Table Global Market Sickle Cell Disease Drug Average Price (USD/Pcs) of Key Manufacturers (2013-2018)
Figure Global Market Sickle Cell Disease Drug Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Sickle Cell Disease Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Sickle Cell Disease Drug Product Category
Figure Sickle Cell Disease Drug Market Share of Top 3 Manufacturers
Figure Sickle Cell Disease Drug Market Share of Top 5 Manufacturers
Table Global Sickle Cell Disease Drug Capacity (K Pcs) by Region (2013-2018)
Figure Global Sickle Cell Disease Drug Capacity Market Share by Region (2013-2018)
Figure Global Sickle Cell Disease Drug Capacity Market Share by Region (2013-2018)
Figure 2017 Global Sickle Cell Disease Drug Capacity Market Share by Region
Table Global Sickle Cell Disease Drug Production by Region (2013-2018)
Figure Global Sickle Cell Disease Drug Production (K Pcs) by Region (2013-2018)
Figure Global Sickle Cell Disease Drug Production Market Share by Region (2013-2018)
Figure 2017 Global Sickle Cell Disease Drug Production Market Share by Region
Table Global Sickle Cell Disease Drug Revenue (Million USD) by Region (2013-2018)
Table Global Sickle Cell Disease Drug Revenue Market Share by Region (2013-2018)
Figure Global Sickle Cell Disease Drug Revenue Market Share by Region (2013-2018)
Table 2017 Global Sickle Cell Disease Drug Revenue Market Share by Region
Figure Global Sickle Cell Disease Drug Capacity, Production (K Pcs) and Growth Rate (2013-2018)
Table Global Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table North America Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Europe Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Global Sickle Cell Disease Drug Consumption (K Pcs) Market by Region (2013-2018)
Table Global Sickle Cell Disease Drug Consumption Market Share by Region (2013-2018)
Figure Global Sickle Cell Disease Drug Consumption Market Share by Region (2013-2018)
Figure 2017 Global Sickle Cell Disease Drug Consumption (K Pcs) Market Share by Region
Table North America Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Europe Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table China Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Japan Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Southeast Asia Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table India Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Global Sickle Cell Disease Drug Production (K Pcs) by Type (2013-2018)
Table Global Sickle Cell Disease Drug Production Share by Type (2013-2018)
Figure Production Market Share of Sickle Cell Disease Drug by Type (2013-2018)
Figure 2017 Production Market Share of Sickle Cell Disease Drug by Type
Table Global Sickle Cell Disease Drug Revenue (Million USD) by Type (2013-2018)
Table Global Sickle Cell Disease Drug Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Sickle Cell Disease Drug by Type (2013-2018)
Figure 2017 Revenue Market Share of Sickle Cell Disease Drug by Type
Table Global Sickle Cell Disease Drug Price (USD/Pcs) by Type (2013-2018)
Figure Global Sickle Cell Disease Drug Production Growth by Type (2013-2018)
Table Global Sickle Cell Disease Drug Consumption (K Pcs) by Application (2013-2018)
Table Global Sickle Cell Disease Drug Consumption Market Share by Application (2013-2018)
Figure Global Sickle Cell Disease Drug Consumption Market Share by Applications (2013-2018)
Figure Global Sickle Cell Disease Drug Consumption Market Share by Application in 2017
Table Global Sickle Cell Disease Drug Consumption Growth Rate by Application (2013-2018)
Figure Global Sickle Cell Disease Drug Consumption Growth Rate by Application (2013-2018)
Table Acceleron Pharma Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acceleron Pharma Inc Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (Acceleron Pharma Inc) and Gross Margin (2013-2018)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table Addmedica SAS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Addmedica SAS Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Addmedica SAS Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure Addmedica SAS Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure Addmedica SAS Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table Angiocrine Bioscience Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table Annexin Pharmaceuticals AB Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table ArQule Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ArQule Inc Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ArQule Inc Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure ArQule Inc Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure ArQule Inc Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table Bio Products Laboratory Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table Bioverativ Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bioverativ Inc Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bioverativ Inc Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure Bioverativ Inc Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure Bioverativ Inc Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table bluebird bio Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table bluebird bio Inc Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure bluebird bio Inc Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure bluebird bio Inc Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure bluebird bio Inc Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Co Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table Calimmune Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Calimmune Inc Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Calimmune Inc Sickle Cell Disease Drug Production Growth Rate (2013-2018)
Figure Calimmune Inc Sickle Cell Disease Drug Production Market Share (2013-2018)
Figure Calimmune Inc Sickle Cell Disease Drug Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sickle Cell Disease Drug
Figure Manufacturing Process Analysis of Sickle Cell Disease Drug
Figure Sickle Cell Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Sickle Cell Disease Drug Major Manufacturers in 2017
Table Major Buyers of Sickle Cell Disease Drug
Table Distributors/Traders List
Figure Global Sickle Cell Disease Drug Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Sickle Cell Disease Drug Price (Million USD) and Trend Forecast (2018-2025)
Table Global Sickle Cell Disease Drug Production (K Pcs) Forecast by Region (2018-2025)
Figure Global Sickle Cell Disease Drug Production Market Share Forecast by Region (2018-2025)
Table Global Sickle Cell Disease Drug Consumption (K Pcs) Forecast by Region (2018-2025)
Figure Global Sickle Cell Disease Drug Consumption Market Share Forecast by Region (2018-2025)
Figure North America Sickle Cell Disease Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure North America Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Sickle Cell Disease Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Europe Sickle Cell Disease Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Sickle Cell Disease Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure China Sickle Cell Disease Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Sickle Cell Disease Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Japan Sickle Cell Disease Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Sickle Cell Disease Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Southeast Asia Sickle Cell Disease Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Sickle Cell Disease Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure India Sickle Cell Disease Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Sickle Cell Disease Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Table Global Sickle Cell Disease Drug Production (K Pcs) Forecast by Type (2018-2025)
Figure Global Sickle Cell Disease Drug Production (K Pcs) Forecast by Type (2018-2025)
Table Global Sickle Cell Disease Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Sickle Cell Disease Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Sickle Cell Disease Drug Price Forecast by Type (2018-2025)
Table Global Sickle Cell Disease Drug Consumption (K Pcs) Forecast by Application (2018-2025)
Figure Global Sickle Cell Disease Drug Consumption (K Pcs) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source